India's Mankind Pharma gains on higher quarterly profit
26/10/2026 09:56
BUZZ-India's Mankind Pharma gains on higher quarterly profit ** Shares of India's Mankind Pharma MNKI.NS rise 5.1% to 2,325.20 rupees
** Drugmaker reports September-quarter consolidated net profit increases 38.9% Y/Y to 7.11 billion rupees ($74.68 million) from 5.12 billion rupees a year earlier
** Adds that its consolidated revenue from operations rose 17.3% Y/Y to 43.38 billion rupees in the quarter
** Stock rated "buy" on average by 19 analysts; median PT is 2,850 rupees - LSEG-compiled data
** Stock up 5.9% YTD
($1 = 95.2100 Indian rupees)
(Reporting by Payel Das in Bengaluru)
Recent news on Mankind Pharma
See all newsIndia's Mankind Pharma heads for best day in over 3 years as Q2 hints at recovery
Mankind Pharma's quarterly profit jumps 39% on strong chronic drug demand
India's Mankind Pharma gains on higher quarterly profit
Brief: Mankind Pharma Says To Buy 70% Majority Stake In Armed Cell Therapeutics Through Unit
Kotak upgrades India's Mankind Pharma to 'buy' on signs of business recovery